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Abstract
Background:  Hepatic  angiosarcoma  is  a  rare  vascular  malignancy  that  accounts  for  2%  of  all
hepatic primary  tumours.  The  diagnosis  is  difﬁcult,  especially  if  the  patient  does  not  have
history of  exposure  to  carcinogens,  which  are  considered  as  risk  factors.  The  diagnosis  is  made
by histopathology,  but  in  a  considerable  percentage  it  can  only  be  accomplished  by  autopsy.
The performing  of  ﬁne  needle  aspiration  biopsy  can  lead  to  bleeding,  with  limitations  in  its  use.
Clinical case:  A  41  year-old  male,  with  no  history  of  exposure  to  carcinogens,  who  developed
abdominal pain  secondary  to  a  haemoperitoneum  due  to  tumour  rupture,  was  diagnosed  by
imaging  methods  with  a  giant  cavernous  hepatic  haemangioma.  He  was  initially  treated  with
embolisation,  and  later  with  a  liver  transplant.  After  six  months  he  developed  haemoptysis
secondary  to  lung  metastasis.  The  autopsy  reported  metastatic  hepatic  angiosarcoma.
Discussion:  This  condition  has  been  related  to  carcinogen  exposure,  with  malignant  transforma-
tion from  a  benign  vascular  neoplasia  being  proposed  as  a  hypothesis.  The  differential  diagnosis
can be  achieved  with  imaging  studies  such  as  CT  scan,  and  the  deﬁnitive  diagnosis  is  made  by
histopathology  with  immunohistochemistry  tests,  with  35--100%  being  made  in  the  autopsy.
Conclusion:  Hepatic  angiosarcoma  is  a  malignant  vascular  neoplasia,  the  potential  curative
option is  surgery  with  tumour  free  margins.  Liver  transplantation  remains  controversial  because
of its  poor  prognosis  in  the  short  term.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
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Angiosarcoma  hepático  y  trasplante  hepático:  reporte  de  caso  y  revisión  de
bibliografía
Resumen
Antecedentes:  El  angiosarcoma  hepático  es  un  tumor  vascular  raro  y  maligno  el  cual  representa
el 2%  de  todos  los  tumores  hepáticos  primarios.  La  orientación  diagnóstica  es  difícil,  en  especial
cuando el  paciente  no  tiene  antecedente  de  exposición  a  carcinógenos  relacionados  como  fac-
tores de  riesgo.  El  diagnóstico  es  histopatológico,  y  en  la  mayoría  solo  se  logra  con  autopsia  ya
que la  toma  de  biopsia  por  aspiración  con  aguja  ﬁna  conlleva  riesgo  de  sangrado  lo  que  limita
su utilización.
Caso  clínico: Masculino  de  41  an˜os  de  edad  el  cual  no  tiene  antecedentes  de  exposición  a
carcinógenos.  Comienza  con  dolor  abdominal  secundario  a  hemoperitoneo  por  rotura  tumoral  y
es diagnosticado  por  estudios  de  imagen  con  hemangioma  hepático  cavernoso  gigante,  tratado
inicialmente  con  embolización  y  posteriormente  con  trasplante  hepático.  Seis  meses  después  se
presenta con  hemoptisis  por  metástasis  pulmonares.  En  la  necropsia  se  reporta:  angiosarcoma
hepático  metastásico.
Discusión:  El  angiosarcoma  hepático  se  ha  relacionado  con  la  exposición  a  carcinógenos,  y
continúa siendo  una  hipótesis  su  transformación  a  partir  de  una  neoplasia  vascular  benigna.  En
el diagnóstico  diferencial  son  útiles  los  estudios  de  imágenes,  como  la  tomografía  contrastada.
Sin embargo,  el  diagnóstico  deﬁnitivo  es  histopatológico  con  pruebas  inmunohistoquímicas,  que
en el  35-100%  solo  establece  en  la  autopsia.
Conclusión:  Es  una  neoplasia  vascular  maligna,  donde  la  cirugía  tiene  un  rol  potencialmente
curativo  cuando  se  practica  resección  con  márgenes  libres.  El  trasplante  hepático  es  contro-
vertido ya  que  tiene  pobre  pronóstico  a  corto  plazo.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
h
o
H
a
P
v
c
s
b
v
i
e
U
f
C
A
H
o
w
a
inal  pain  in  the  epigastrium  which  later  spread  to  theBackground
In  recent  reports  liver  angiosarcoma  has  been  associated
with  thorium  dioxide,  arsenic  powder  and  vinyl  chloride  as
risk  factors.  However,  there  have  been  cases  where  no  trigg-
ering  factor  has  been  found.1--3
Liver  angiosarcoma  is  difﬁcult  to  differentiate  from
cavernous  haemangioma  in  radiological  studies  as  liver
haemangioma  are  major  lesions,  heterogeneous  in  appear-
ance  which  may  have  intratumoral  haemorrhaging  and
necrosis,  leading  to  diagnostic  confusion  with  malignant
vascular  tumours.4 Whelan  et  al.5 reported  that  one  of
the  standard  imaging  characteristics  of  liver  angiosarco-
mas  is  peripheral  nodular  enhancement  in  the  late  arterial
phase.  2-Deoxy-2-ﬂuoro-d-glucose  positron  emission  tomo-
graphy  (PET)  is  useful  for  differentiating  benign  vascular
tumours  from  malignant  ones,  especially  those  which  are
considerable  in  size.4--6
Risk  of  spontaneous  rupture  and  bleeding  of  the  angiosar-
coma  is  documented  in  approximately  15--27%  and  has  an
effect  on  prognosis,  since  the  beginnings  of  tumour  cells
are  created.  Furthermore,  the  spontaneous  rupture  of  a  liver
haemangioma  is  rare  and  its  frequency  is  calculated  as  under
1%,  generally  in  large  tumours  located  on  the  lateral  or
underside  of  the  liver;  when  there  is  a  ruptured  liver  tumour
malignant  aetiology  should  ﬁrst  be  suspected;  transcatheter
arterial  embolisation  is  the  initial  treatment.9Due  to  a  poor  prognosis  of  patients  with  liver  angiosar-
coma,  resection  surgery  is  the  only  deﬁnitive  treatment
and  although  complete  resection  is  possible,  recurrence  is
w
b
Tighly  frequent.  The  average  survival  rate  for  the  majority
f  patients  is  11  months.10,11
The  natural  history  of  liver  angiosarcoma  is  little  known.
owever,  when  it  is  diagnosed  it  is  often  already  at  an
dvanced  stage  with  an  average  diameter  of  15--65  mm.
erforming  a  biopsy  can  represent  a  challenge  due  to  its
ascular  nature.12
When  a  small  tumour  is  discovered  with  haemangioma
haracteristics  follow-up  with  imaging  studies  is  required,
ince  if  rapid  growth  presents  liver  angiosarcoma  must
e  considered  as  a  possible  diagnosis.12,13 Mortality  rate
aries  between  70%  and  100%;  Immunohistochemical  stain-
ng  conﬁrms  diagnosis,  usually  with  the  expression  of
ndothelial  markers  which  included  factor  VIII,  CD31,  CD34,
lex  europaeus  agglutin  I  and  vascular  endothelial  growth
actor.14
linical case
 41  year  old  male,  with  no  prior  family  history  of  note.
e  stated  that  he  did  not  drink  alcohol,  smoke  tobacco,
r  take  drugs  nor  did  he  have  any  tattoos.  He  presented
ith  no  chronic  degenerative  diseases,  nor  suffered  from
ny  allergies.  His  blood  group  was  O+.
His  condition  began  in  March  2012  with  sharp  abdom-hole  abdomen.  He  presented  with  haemodynamic  insta-
ility  and  therefore  presented  at  the  hospital  in  Houston,
exas,  U.S.A.  (his  place  of  residence  at  the  time),  where
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Figure  1  Abdominal  axial  CT  scan  with  oral  and  intravenous
contrast  enhancement  in  arterial  phase  which  shows  liquid  ﬂuid
in the  abdominal  cavity,  predominantly  perihepatic  and  peris-
splenic  (black  arrows)  and  a  rounded  tumour,  heterogeneously
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Figure  2  Axial  CT  scan  of  the  chest,  pulmonary  window;  small
s
a
g
w
S
a
t
t
f
v
t
y
l
b
t
0.8  mg/dl,  and  lactate  dehydrogenase  at  3371  U/l,  alpha-
fetoprotein  at  0.7  ng/ml.  Difﬁculty  in  breathing  persisted;
the  patient  received  intubation,  which  deteriorated  intoontrasted,  which  occupies  practically  the  entire  liver  (white
rrow).
assive  intrabdominal  bleeding  was  diagnosed  secondary  to
avernous  haemangioma,  bilobular  in  appearance  (Fig.  1);
ngiographic  embolisation  was  performed,  with  cessation
f  bleeding.  When  the  patient  had  recovered  an  ortho-
opic  liver  transplant  of  the  right  lobe  was  performed,  with
lood  type  compatibility,  with  standard  surgical  reconstruc-
ion  for  the  live  donor  in  May  2012,  in  a  private  hospital  in
he  city  of  after  Guadalajara,  Jalisco.  Positive  serology  for
MV  IgG  for  both  the  donor  and  the  recipient  was  present.
he  patient  was  discharged  8  days  after  surgical  procedure
ith  immunosuppression  therapy  which  included  tacrolimus,
ycophenolic  acid  and  prednisone.
In  September  the  patient  presented  with  haemoptysis
nd  dyspnoea,  and  was  admitted  to  a  private  hospital,
here  a  computed  tomography  (CT)  chest  scan  was  indi-
ated  (Fig.  2).  A  bronchoscopy  was  performed  and  cultures
nd  biopsies  were  taken,  which  tested  negative  for  malig-
ancy,  tuberculosis  or  fungal  infection.  Plain  and  contrasted
T  scan  of  the  abdomen  was  indicated  which  showed  mul-
iple,  rounded  lesions,  hypodense  in  the  liver  graft  (Fig.  3);
T  scan-guided  biopsy  was  performed  which  tested  negative
o  malignancy.
The  patient  was  admitted  to  our  hospital  in  October  2012
o  continue  with  a  diagnostic  and  therapeutic  approach;  on
dmittance  tegumentary  paleness  was  noted,  together  with
achycardia,  difﬁculty  in  breathing,  active  haemoptysis  and
symptomatic  abdomen.
Laboratory  tests  on  hospital  admittance  revealed:  leuko-
ytes  10.7  thousand/l, red  blood  cells  5.6  g/dl,  haema-
ocrit  20.3%,  platelets  124  thousand/l, Na  127  mmol/l,
rothrombin  time  14.2/12  seg,  INR  1.12,  lactate  dehydro-
enase  1753  U/l,  total  bilirubin  levels  1.5  mg/dl,  direct
ilirubins  0.3  mg/dl.  3  globular  packs  were  transfused  and
odium  replacement  was  initiated.Bronchoscopy  was  again  performed,  identifying:  vocal
olds  with  traces  of  blood,  oedematous  and  hyperemic
ronchial  mucosa,  with  no  identiﬁcation  of  compactions  or
F
wolid and  rounded  tumours  are  observed,  with  halos  (white
rrows),  polished  glass  images  (arrow  head).
rowths  at  any  level;  biopsies  and  cultures  of  secretions
ere  taken  (testing  positive  to  Pseudomonas  aeruginosa,
treptococcus  viridans).  A  skin  test  was  indicated  for  PPD
nd  histoplasmin,  which  was  not  reactive.  The  patient
ested  non-reactive  to  HIV  and  hepatitis  B  and  C.
The  Doppler  ultrasound  of  the  graft  reported:  preserva-
ion  of  venous  and  arterial  structures,  with  normal  pulse,
ocal  lesion  at  liver  parenchymal  level  with  permeability  of
ascular  structures.  The  patient’s  general  status  continued
o  deteriorate,  and  he  presented  with  massive  haemopt-
sis  (>  600  ml/24  h).  Laboratory  tests  showed:  increase  in
eukocytes  to  19.2  thousands/l, with  improvement  of  red
lood  cell  levels  compared  with  baseline  ones  at  10.2  g/dl;
otal  bilirubin  increase  to  2.2  mg/dl,  direct  bilirubin  atigure  3  Plain  abdominal  CT  scan.  Multiple  rounded  tumours,
hich are  hypodense  in  liver  graft  (black  arrow).
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iFigure  4  Liver  graft  with  multiple,  rounded  tumours,  charac-
teristically  haemorrhagic.
cardiopulmonary  arrest  and  did  not  respond  to  cardiopul-
monary  resuscitation  manoeuvres.  He  died  on  the  6th  day
after  admittance.
An  autopsy  was  performed,  where  we  observed  rounded,
vascularised  tumours  throughout  the  liver  graft,  involving
the  hepatic  artery  and  portal  vein  (Fig.  4),  in  pulmonary
parenchyma,  multiple  metastases  of  small  tumours,  with
bleeding  (Fig.  5).  Metastasis  was  also  present  in  the  spleen,
suprarenal  glands  and  pancreas.
Histologically,  the  spindle  cells  were  grouped  into  strands
and  invaded  the  vascular  cavities,  with  several  areas  of
necrosis  and  atypical  nuclei.  Immunohistological  staining
tested  positive  for  CD31  and  CD34,  thus  conﬁrming  the  diag-
nosis  of  liver  angiosarcoma  (Fig.  6).
Discussion
Liver  angiosarcoma  is  a  rare  malignant  tumour  which  rep-
resents  under  2%  of  primary  liver  tumours.1 Falk  et  al.2
reported  a  series  of  168  cases  between  1964  and  1974,  of
which  37  (22%)  were  associated  with  vinyl  chloride  but  in
the  majority  of  cases  no  aetiological  factors  were  found.
Exposure  to  vinyl  chloride  is  associated  with  mutations  of
Figure  5  Pulmonary  parenchyma  where  metastatic  tumours
are noted,  which  are  punctiform  and  haemorrhagic.
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enes  K-ras  and  p53.  The  latency  period  between  exposure
nd  disease  appearance  may  be  between  9  and  35  years.3,4
Other  carcinogens  such  as  thorium  dioxide  and  arsenic
ave  been  associated  with  its  aetiology;  however,  expo-
ure  to  these  chemicals  is  rare  and  in  the  majority  of  cases
here  is  no  deﬁned  aetiology,  there  are  reports  of  cases
here  an  association  was  found  with  Schistosoma  japon-
ca,  exposure  to  cyclophosphamide  and  the  prolonged  use  of
nabolic  androgenic  steroids.5 The  hypothesis  of  a malignant
ransformation  from  cavernous  liver  haemangioma  has  been
eveloped  since  1991,  with  a case  of  a  solitary  encapsu-
ated  liver  tumour,  which  showed  a  cavernous  haemangioma
urrounded  by  an  angiosarcoma.  There  have  been  several
eported  cases  of  angiosarcoma  developing  from  vascular
alformations/haemangiomas,  all  of  the  patients  being  in
heir  60s  and  70s.  A  study  in  2006  reported  that  83%  of
ngiosarcomas  had  suffered  the  loss  of  one  allele  in  chro-
osome  17p13  (p53),  66%  in  13q14  (RB),  50%  11p13  (WT-1);
n  comparison,  60%  of  the  haemangiomas  had  a  loss  of  alleles
n  17p13,  13q14,  but  only  20%  in  11p13;6 however,  associa-
ion  is  not  yet  clear  between  benign  vascular  lesions  and
ngiosarcoma.
Angiosarcoma  is  characterised  by  rapid  growth,  the
ajority  of  patients  appear  to  be  suffering  from  chronic  liver
isease.  Abdominal  pain,  weakness,  fatigue  and  weight  loss
re  frequent  symptoms  with  hepatosplenomegalia,  ascites,
aundice  and  anaemia  being  the  major  clinical  symptoms.6
pontaneous  rupture  of  liver  angiosarcoma  is  reported  in
5--27%  of  cases.7
Benign  tumours  such  as  cavernous  haemangioma  carry
 low  risk  of  rupture,  under  1%,  and  malignant  neoplasia
hould  be  suspected  when  there  is  a  tumour  rupture.5 When
he  clinical  presentation  is  accompanied  by  haemoptysis  pul-
onary  metastases  should  be  the  suspected  diagnosis.8
There  are  no  speciﬁc  tumour  markers  for  this  type  of
umour;  Alpha-fetoprotein  and  CA  19-9  are  generally  at
ormal  of  slightly  elevated  levels.  In  imaging  studies  (tomo-
raphy  or  magnetic  resonance)  liver  angiosarcomas  appear
s  multiple  nodules,  dominant  masses  or  a  lesion  with  diffuse
nﬁltration.9
Tumour  diagnosis  is  difﬁcult,  particularly  if  the  patient
as  no  history  of  any  exposure  to  speciﬁc  carcinogens;  it
s  easy  to  confuse  this  type  of  neoplasias  with  cavernous
aemangioma  in  imaging  study  ﬁndings.9--11 In  CT  scans
ome  lesions  usually  have  increased  uptake  which  reﬂect
he  increase  of  the  lesion  vascularity,  others  are  hypodense
r  normal.  Imaging  studies  which  mimic  haemangiomas  are
sually  attributed  to  image  interpretation  in  a  single  (late)
hase  and  with  assessment  established  in  relation  to  the
epatic  parenchyma  and  not  with  vascular  structures,  such
s  the  aorta  or  hepatic  artery.  The  image  of  a  solitary  lesion
s  uncommon  for  angiosarcoma  and  the  presence  of  multiple
esions  is  not  typical  of  haemangioma.9--12
Angiosarcoma  presents  with  early  metastasis  to  other
rgans  such  as  the  lung,  spleen  or  bone.10 In  plain  chest
-rays  there  may  be  diffuse  inﬁltrations.  The  most  common
ndings  in  CT  chests  scans  indicated  for  angiosarcoma
etastasis  are  multiple  solid  tumours.  When  they  present
ith  haemorrhaging  they  result  in  a  ground-glass  opacity
maging  known  as  a halo  sign  and  this  occurs  in  32%  of
atients.  To  a  lower  extent  cystic  changes  may  be  found
n  the  thin  walls  (13%)  which  when  distributed  in  the
514  L.D.  Huerta-Orozco  et  al.
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1igure  6  Histology,  endothelial  cells  which  are  grouped  into
nd CD34.
leural  cavities  increase  the  incidence  of  pneumothorax  or
aemothorax.12
The  performing  of  ﬁne  needle  aspiration  biopsy  makes
iagnosis  difﬁcult  and  may  lead  to  bleeding.12
Deﬁnitive  diagnosis  is  anatomopathological  and  in
5--100%  of  cases  is  reached  during  autopsy.9--13 Mortality
ates  vary  between  70%  and  100%.  Assessment  must  be
ade  by  an  expert  pathologist,  since  presentation  varies
rom  well  differentiated  angiosarcomas  which  form  vascular
hannels  that  may  mimic  a  benign  tumour,13 to  poorly  dif-
erentiated  ones  where  there  is  a  presence  of  endothelial
umour  cells  which  are  epitheloid,  rounded,  or  spindle-like
n  appearance  and  have  prominent  pleomorphic  and  hyper-
hromatic  nuclei,  with  vascular  space  which  are  cavernous
n  appearance.14
Immunohistochemical  staining  is  useful  for  conﬁrming
iagnosis,  and  usually  expresses  endothelial  markers  which
nclude  VIII,  CD31,  CD34,  agglutin  I  Ulex  europaeus  and  vas-
ular  endothelial  growth  factor.14
Differential  diagnosis  must  be  established  with  visceral
aposi  sarcoma,  haemorrhagic  hepatocellular  carcinoma,
ascular  leiomiosarcoma,  malignant  epitheliod  haeman-
ioendothelimoa,  diffuse  metastatic  processes  and  hepatic
eliosis.15
Survival  rates  for  patient  with  hepatic  angiosarcoma  are
oor:  the  mean  rate  is  6  months  with  no  treatment,  and
ven  with  treatment  there  is  a  3%  2-year  patient  survival
ate.  Standard  treatment  for  liver  angiosarcoma  is  surgi-
al  resection,16 although  in  under  20%  of  cases  tumours  are
ocalised  and  resectionable.  Liver  transplant  is  controver-
ial  as  treatment  due  to  high  recurrence  and  poor  prognostic
actors.17 In  the  majority  of  cases  the  tumours  are  not  resec-
ionable  due  to  their  size  and  the  presence  of  metastasis.
iver  angiosarcoma  is  resistant  to  radiotherapy.  The  major-
ty  of  patients  with  metastatic  angiosarcoma  are  treated
ith  chemotherapy;  however,  no  chemotherapy  regimens
ave  been  established;  several  of  the  most  commonly
sed  agents  are:  doxorubicin,  ifosfamide,  gemcitabine,  tax-
nes,  imatinib,  interferon,  cisplatin,  cyclophosphamide  and
rinotecan.18,19
onclusioniver  angiosarcoma  is  a  rare  tumour  which  is  difﬁcult  to  diag-
ose  and  requires  thorough  analysis  with  the  use  of  a series
f  imaging  studies  and  a  high  index  of  disease  suspicion.  The
1ds,  invading  vascular  spaces  and  which  test  positive  for  CD31
nly  curative  treatment  option  is  early  resection  with  neg-
tive  resection  margins  and  no  metastasis.  Moreover,  liver
ransplant  for  this  type  of  tumours  is  controversial  due  to
he  high  rate  of  recurrence.
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